Specifically, the p.Arg1076Cys MSH6 mutation has been previously reported as pathogenic for Lynch syndrome [57] and various types of cancer, such as lung [58], pancreatic [59] and breast cancer [60]. Here, MSH6 is linked to breast cancer.